LNTH Lantheus Holdings, Inc.

102.10USD+0.10%Mkt Cap: 6.68B USDP/E: 25.40

Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in diagnosis and treatment of heart, cancer, and other diseases worldwide. The company offers …

Institutional holders20 on file

Key Statistics

Company
Market Cap6.68B USD
Enterprise Value6.62B USD
Revenue (TTM)1.56B USD
Gross Profit941.95M USD
Net Income (TTM)233.56M USD
Revenue/Share23.96 USD
Last Price102.10 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees1.2K
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)25.40
P/E (Forward)15.34
PEG—
EV/EBITDA18.66
EV/Revenue4.24
P/S4.27
P/B4.92
EPS (TTM)4.02 USD
EPS (Forward)6.65 USD
52W Range
50.1584% of range111.86
52W High111.86 USD
52W Low50.15 USD
Profitability
Gross Margin61.10%
Oper. Margin16.88%
EBITDA Margin22.71%
Profit Margin15.15%
ROE21.43%
ROA10.49%
ROIC17.40%
ROCE16.66%
Growth
Revenue Growth1.50%
Earnings Growth-19.50%
Cash Flow & Leverage
Operating CF390.14M USD
CapEx (TTM)41.50M USD
FCF Margin25.84%
FCF Yield6.05%
Net Debt-59.33M USD
Net Debt/EBITDA-0.17
Net Debt/FCF-0.15
Balance Sheet
Debt/Equity0.57
Current Ratio3.25
Quick Ratio2.98
Book Value/Sh20.74 USD
Cash/Share10.45 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating2.9 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)105.99 USD
Upside (mean)+3.8%
Target Range102.50 USD – 115.00 USD
102.50+3.8% to mean115.00
# Analysts7
Ownership
Shares Out.65.40M
Float60.43M
Insiders1.74%
Institutions102.86%
Short Interest
Short Ratio3.6d
Short % Float6.52%
Short % Out.5.58%
Shares Short3.64M
Short (prev mo.)3.78M
Technical
SMA 50100.39 (+1.7%)
SMA 20093.64 (+9.0%)
Beta0.03
S&P 52W Chg12.00%
Avg Vol (30d)1.06M
Avg Vol (10d)993.79K
Technical Indicators
RSI (14)68.4
MACD0.4490
MACD Signal0.3240
MACD Hist.+0.1250
BB Upper102.41 USD
BB Middle100.95 USD
BB Lower99.49 USD
BB Width2.90%
ATR (14)0.4311 USD
Vol Ratio (20d)1.62x

About Lantheus Holdings (NASDAQ: LNTH)

›

Lantheus Holdings (NASDAQ: LNTH) is listed on Nasdaq, where its shares trade in USD. It belongs to the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector, and reports about 1,193 employees.

The shares were at 102.10 USD on 19 November 2026, up 90.2% over 52 weeks. Its 52-week range is 50.15 USD to 111.86 USD: the price is 8.7% below the high and 103.6% above the low.

At a market capitalisation of 6.68B USD, it trades at 25.4 times trailing earnings and 15.3 times forward earnings. The median trailing P/E of its 17 largest Drug Manufacturers - Specialty & Generic peers is 24.7, so LNTH is valued in line with them.

Lantheus Holdings reports return on equity of 21.4%, an operating margin of 16.9% and revenue up 1.5% year over year.

It holds more cash than debt, a net cash position of 59.33M USD. Its Piotroski F-score is 4 out of 9, an average reading of its financial health. 7 analysts cover the stock, with an average rating of Hold; their mean price target of 105.99 USD is 3.8% above the current price. The next earnings report is expected on 25 February 2027.